Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase EARLY_PHASE1 1Phase 3 1

Status

Withdrawn 1Completed 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 5Other hematologic neoplasm 2Sarcoma 1Lymphoid 1Genitourinary 1

Conditions

Hematologic Neoplasms 2Sarcoma 1Lymphoma 1Breast Neoplasms 1

Interventions

Cyclophosphamide 415Cytarabine 337fludarabine phosphate 231Rituximab 206Methotrexate 199fludarabine 196venetoclax 174Azacitidine 174Busulfan 169Filgrastim 145Whole-Body Irradiation 143Mycophenolic Acid 143Peripheral Blood Stem Cell Transplantation 141Tacrolimus 138Etoposide 130Vincristine 113Melphalan 110Dexamethasone 110Cyclosporine 102Granulocyte Colony-Stimulating Factor 100Imatinib Mesylate 94Daunorubicin 91Antilymphocyte Serum 91Radiotherapy 84Decitabine 83Dasatinib 76Lenalidomide 75Doxorubicin 71Prednisone 69Idarubicin 68

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Carvedilol × Other hematologic neoplasm × Clear all
NCT02717507 2025-04-23

Carvedilol in Preventing Heart Failure in Childhood Cancer Survivors

Children's Oncology Group

Phase 2 Completed
196 enrolled 26 charts
Other hematologic neoplasm

Hematologic Neoplasms

NCT04190433 2023-05-24

Autophagy Activation for the Alleviation of Cardiomyopathy Symptoms After Anthracycline Treatment, ATACAR Trial

Mayo Clinic

Phase 2 Withdrawn
BreastLymphoidOther hematologic neoplasmSarcoma

Breast Neoplasms, Lymphoma, Sarcoma, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡